There are more than 80 clinical trials in progress globally to test treatments and vaccines targeting COVID-19. We highlight 10 here.
The case fatality rate for patients with COVID-19 and CVD is higher than for cancer, chronic respiratory disease, and diabetes. Here is current guidance from the ACC.
A new study reports that coronavirus remains viable in aerosol for up to 3 hours, a finding that could help inform theories of contagion.
An investigational vaccine against coronavirus disease was administered to the first participant in the country's first clinical trial of an agent to prevent COVID-19 infection.
Fraudulent claims on treatments and cures for COVID-19 infection are flooding social media and other digital communications. Here, 6 samples of misinformation your patients may be reading.
The American Diabetes Association warns that COVID-19 may cause severe complications in patients with diabetes. Here’s how you can help.
Safety and efficacy of apixaban bested rivaroxaban in analysis of new users from a US nationwide commercial healthcare claims database.
Research from China reported in NEJM suggests SARS-CoV-2 transmission potential of patients with minimal or no symptoms, complicating detection and containment picture.
Eliminate waiting room magazines; cross-train staff for all essential functions; reorganize waiting area to “contain” febrile patients. Check, check, check?
Click through definitions and recommendations from the 2017 ACC/AHA hypertension guidelines on these sometimes elusive, often dangerous types of elevated BP.